Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Background: Since 2015, the World Health Organization (WHO) has recommended a commercially available lateral-flow urine LAM test (Alere-LAM) to assist in the diagnosis of tuberculosis (TB) in severely ill people living with HIV (PLHIV). The test can rapidly detect TB in severely ill PLHIV and can id...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gates Open Res
Main Authors: Singhroy, Diane N., MacLean, Emily, Kohli, Mikashmi, Lessem, Erica, Branigan, David, England, Kathleen, Suleiman, Khairunisa, Drain, Paul K., Ruhwald, Morten, Schumacher, Samuel, Denkinger, Claudia M., Waning, Brenda, Van Gemert, Wayne, Pai, Madhukar
Formato: Artigo
Idioma:Inglês
Publicado: F1000 Research Limited 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059561/
https://ncbi.nlm.nih.gov/pubmed/32185366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/gatesopenres.13112.2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares